Boston Scientific Corporation
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
16,608.99 |
19,867.20 |
22,038.91 |
24,275.30 |
26,561.27 |
28,760.25 |
| Przychód Δ r/r |
0.00% |
19.62% |
10.93% |
10.15% |
9.42% |
8.28% |
| Przychód (min) |
16,538.91 |
19,469.02 |
21,529.34 |
24,250.48 |
25,933.21 |
28,080.19 |
| Przychód (max) |
16,679.07 |
20,013.90 |
22,622.79 |
24,300.11 |
26,996.26 |
29,231.25 |
| EBITDA (średnia) |
3,498.20 |
4,184.45 |
4,641.86 |
5,112.89 |
5,594.36 |
6,057.52 |
| EBIT (średnia) |
1,988.56 |
2,378.66 |
2,638.67 |
2,906.43 |
3,180.13 |
3,443.41 |
| EBIT % |
11.97% |
11.97% |
11.97% |
11.97% |
11.97% |
11.97% |
| Zysk netto (średni) |
3,663.35 |
4,432.48 |
5,005.43 |
5,890.91 |
6,464.97 |
7,139.75 |
| Zysk netto % |
22.06% |
22.31% |
22.71% |
24.27% |
24.34% |
24.83% |
| EPS (średnia) |
2.47 |
2.98 |
3.40 |
3.84 |
4.35 |
4.80 |
| Liczba analityków (Przychody) |
23 |
18 |
24 |
25 |
11 |
12 |
| Liczba analityków (EPS) |
19 |
21 |
18 |
10 |
5 |
4 |
| symbol |
BSX |
BSX |
BSX |
BSX |
BSX |
BSX |